No definition available.
Benign neoplasm: Pelvic bones, sacrum and coccyx
CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
140 |
4. Check minimum number of eventsNone |
140 |
5. Include endpointsNone |
140 |
6. Filter based on genotype QC (FinnGen only) |
140 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossis coxae, ossis sacri sive ossis coccygis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pelvic bones, sacrum and coccyx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Pelvic bones, sacrum and coccyx
- Benign neoplasm of bone and articular cartilage
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 995 | 538 | 448 |
| Only index persons | 868 | 483 | 385 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 40.90 | 43.81 | 37.09 |
| Only index persons | 39.57 | 42.49 | 35.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 140 | 90 | 50 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 44.38 | 42.95 | 46.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 114
- Matched controls
- 1141
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
106.6
85
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
35.5
18.3
23
8
21305
ICD-8 Finland
Benign neoplasm of bone and cartilage, Pelvis, sacri, coccygis
+∞
17.1
16
*
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
16.0
15
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
18.6
15.7
24
16
2136A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Pelvic bones, sacrum and coccyx
+∞
14.9
14
*
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
42.7
12.5
15
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
72.6
11.9
13
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
8.1
11.0
25
38
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
+∞
8.4
8
*
9102
FHL
Trepanation or removal of the local bone process
48.4
7.8
9
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
8.5
7.2
15
20
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
73.8
6.5
7
*
9101
FHL
Bone biopsy
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
99
670
2.63
6.40
7.7
9.6
3.9
4.0
e9/l
0.21
93
579
17
46
4.07
5.84
1.2
1.6
—
—
—
0
0
79
511
2.25
5.24
6.0
6.2
1.2
1.2
mmol/l
0.12
67
435
72
465
2.13
4.61
6.0
5.1
1.2
1.2
mmol/l
0.15
67
429
113
874
2.52
4.59
3.9
4.0
15.1
14.8
pmol/l
0.90
106
792
79
533
2.11
4.46
4.5
3.6
0.0
0.0
estimate
0.00
14
113
64
407
2.05
4.16
4.8
3.6
—
—
—
0
0
20
79
2.79
3.83
2.3
3.5
54.3
69.0
ml/min/173m2
1.14
12
39
108
846
2.21
3.83
4.7
3.9
8.6
10.6
mm/h
1.54
102
778
26
119
2.46
3.73
10.0
7.9
—
—
—
0
0
45
262
2.06
3.63
2.4
3.4
534.0
1302.1
ng/l
1.75
37
218
7
9
8.11
3.60
1.0
1.0
—
—
—
0
0
7
9
8.11
3.60
1.0
1.0
—
—
—
0
0
77
546
1.91
3.48
4.5
3.6
0.0
0.0
estimate
0.00
13
107
66
446
1.91
3.44
2.6
2.3
87.5
78.5
nmol/l
1.25
61
395
76
539
1.90
3.41
5.4
4.9
0.0
0.0
estimate
0.00
15
113
125
1060
2.67
3.38
5.0
4.6
1.7
1.9
mu/l
1.02
117
970
9
20
4.73
3.17
1.6
1.3
—
—
—
0
0
41
244
1.96
3.06
1.7
2.1
2.8
3.0
mg/l
0.33
33
207
52
339
1.85
2.94
2.3
2.5
56.3
58.4
u/l
0.21
47
311
21
99
2.32
2.82
2.0
2.0
449.2
368.4
nmol/l
1.13
21
90
16
67
2.57
2.75
2.3
1.5
—
—
—
0
0
84
643
1.77
2.70
4.8
4.2
6.4
6.5
mmol/l
0.16
78
588
58
404
1.74
2.57
2.0
1.8
102.8
97.2
pmol/l
0.35
32
206
78
591
1.72
2.54
5.8
6.2
9.4
10.6
umol/l
1.21
73
561
9
26
3.63
2.53
1.2
1.5
—
—
—
0
0
58
406
1.73
2.51
3.5
3.6
17.8
31.2
ng/l
1.32
39
259
71
529
1.69
2.43
4.3
4.0
—
—
—
0
0
44
287
1.78
2.42
6.0
3.8
0.0
0.0
estimate
0.00
14
112
29
170
1.89
2.23
1.8
1.9
—
—
—
0
0
128
1146
2.36
2.21
18.2
13.8
139.9
139.7
mmol/l
0.48
123
1116
128
1151
2.31
2.10
18.3
13.9
4.0
3.9
mmol/l
0.65
123
1119
52
370
1.64
2.04
3.8
3.5
2.4
2.4
mmol/l
0.11
47
326
42
292
1.63
1.78
1.4
1.2
0.6
1.0
u/ml
0.64
15
82
52
381
1.58
1.78
4.7
3.2
—
—
—
0
0
37
250
1.65
1.75
2.4
2.0
—
—
—
0
0
128
1170
2.10
1.68
16.1
12.5
18.9
22.5
mg/l
0.73
108
900
20
116
1.84
1.59
1.7
1.8
—
—
—
0
0
20
116
1.84
1.59
1.6
1.9
—
—
—
0
0
31
205
1.66
1.58
1.4
1.3
24.0
31.6
iu/ml
—
8
72
63
498
1.48
1.47
3.0
2.5
125.8
99.0
ug/l
0.28
58
456
9
42
2.22
1.36
1.4
1.4
—
—
—
0
0
5
18
2.84
1.29
1.0
1.1
—
—
—
0
0
18
113
1.68
1.12
6.1
6.1
105.6
103.9
mmol/l
1.12
18
108
7
34
2.11
1.04
1.7
1.4
—
—
—
0
0
128
1204
1.74
1.02
19.8
14.4
73.8
74.3
umol/l
0.10
128
1204
11
61
1.87
1.01
1.5
1.3
—
—
—
0
0
115
1059
1.48
0.98
4.1
3.8
1.3
1.2
mmol/l
0.19
108
980
34
256
1.43
0.98
1.7
1.7
3.7
0.9
mg/l
0.42
23
195
27
197
1.46
0.91
1.3
1.3
27.3
6.1
u/ml
0.65
17
77
93
834
1.34
0.87
3.1
3.4
—
—
—
0
0
8
45
1.82
0.86
2.0
1.8
—
—
—
0
0
26
192
1.43
0.83
4.3
4.6
20.3
21.8
%
0.20
13
80
10
58
1.78
0.82
1.6
1.5
—
—
—
0
0
8
48
1.71
0.80
2.0
1.9
—
—
—
0
0
116
1082
1.42
0.80
14.5
11.6
84.7
84.6
ml/min/173m2
0.03
100
864
120
1126
1.46
0.80
5.1
4.6
2.6
2.8
mmol/l
1.98
115
1047
118
1104
1.44
0.79
4.6
4.2
1.4
1.5
mmol/l
0.68
113
1030
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
24
177
1.43
0.77
3.0
2.7
1.4
1.0
e6/l
0.13
16
90
7
39
1.84
0.73
1.4
1.1
—
—
—
0
0
5
25
2.04
0.73
2.8
2.0
—
—
—
0
0
9
58
1.59
0.71
9.6
4.3
24.7
24.8
mmol/l
—
9
58
118
1111
1.40
0.69
4.7
4.2
4.4
4.7
mmol/l
3.31
113
1044
5
27
1.88
0.69
1.4
1.4
1.2
36.8
e6/l
—
5
20
5
27
1.88
0.69
1.4
1.4
13.0
2.6
e6/l
—
5
19
5
28
1.81
0.67
2.0
1.1
—
—
—
0
0
5
30
1.69
0.62
1.0
2.1
—
—
—
0
0
27
213
1.33
0.60
1.5
1.4
—
—
—
0
0
6
35
1.75
0.58
1.7
2.1
—
—
—
0
0
6
40
1.52
0.52
1.3
1.5
—
—
—
0
0
16
119
1.39
0.51
4.3
4.7
35.9
33.1
%
0.55
11
76
14
102
1.41
0.49
7.8
6.8
4.8
5.1
kpa
0.60
14
97
12
85
1.45
0.48
1.6
1.8
—
—
—
0
0
7
47
1.51
0.48
1.1
2.2
—
—
—
0
0
7
49
1.45
0.46
1.3
1.6
—
—
—
0
0
36
307
1.23
0.45
3.4
2.9
2.2
0.4
e6/l
0.50
29
222
32
270
1.24
0.44
1.8
1.6
—
—
—
0
0
8
56
1.45
0.43
3.3
3.4
1.8
1.3
mmol/l
—
8
44
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
8
61
1.33
0.40
3.3
3.3
5.3
5.1
kpa
—
8
55
18
143
1.30
0.39
2.8
2.6
0.5
0.8
ug/l
1.36
11
80
6
44
1.38
0.35
4.5
3.6
37.5
48.1
%
—
6
44
6
46
1.32
0.33
1.3
1.5
—
—
—
0
0
6
46
1.32
0.33
1.3
1.5
—
—
—
0
0
6
46
1.32
0.33
1.3
1.5
—
—
—
0
0
13
102
1.30
0.31
1.8
2.0
—
—
—
0
0
9
74
1.23
0.26
1.0
1.0
—
—
—
0
0
11
87
1.29
0.25
2.9
3.5
6.1
5.8
kpa
0.30
11
87
5
38
1.33
0.23
1.8
3.0
2.6
3.2
g/l
—
5
32
5
41
1.23
0.22
1.8
2.8
6.6
7.9
g/l
—
5
33
5
41
1.23
0.22
1.8
2.8
4.0
3.9
g/l
—
5
32
5
41
1.23
0.22
1.8
2.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
19
165
1.18
0.20
4.2
3.1
0.3
3.3
e6/l
2.38
12
79
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
98.5
—
0
14
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
11
127
0.85
0.13
2.3
1.8
—
—
—
0
0
17
153
1.13
0.11
2.0
1.7
1.8
1.4
%
1.28
17
134
105
1030
1.08
0.10
7.0
5.3
40.3
39.3
mmol/mol
0.46
98
966
21
196
1.08
0.07
3.4
3.3
12.8
98.4
ng/l
1.05
12
136
12
109
1.11
0.06
4.9
3.5
—
—
—
0
0
18
169
1.07
0.05
1.8
2.1
—
—
—
0
0
108
1092
0.95
0.05
14.8
13.0
40.5
40.4
%
0.06
77
846
83
819
1.03
0.03
3.2
2.9
30.8
45.6
u/l
3.92
74
776
18
184
0.98
0.00
1.9
2.2
—
—
—
0
0
110
1095
1.02
0.00
4.9
4.2
6.0
5.8
mmol/l
0.35
99
1017
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
7.8
—
0
5
0
6
0.00
0.00
0.0
5.7
—
215.5
—
0
6
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
8
84
0.95
0.00
1.1
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
8
79
1.01
0.00
1.5
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
194.6
—
0
8
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
5
51
0.98
0.00
2.0
2.0
34.0
42.5
u/l
—
5
45
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
120.9
—
0
7
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX – Benign neoplasm: Pelvic bones, sacrum and coccyx
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data